DrugPatentWatch Database Preview
Drugs in Development Information for Navitoclax
Summary for Navitoclax
| US Patents | 122 |
| International Patents | 1,489 |
| US Patent Applications | 250 |
| WIPO Patent Applications | 104 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2013-06-01) |
| Vendors | 63 |
US Patents for Navitoclax
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Navitoclax | ➤ Sign Up | Apoptosis promoters | Abbott Laboratories (Abbott Park, IL) | ➤ Sign Up |
| Navitoclax | ➤ Sign Up | Apoptosis promoters | Abbott Laboratories (Abbott Park, IL) | ➤ Sign Up |
| Navitoclax | ➤ Sign Up | Treatment of myeoproliferative diseases | Abbott Laboratories (Abbott Park, IL) | ➤ Sign Up |
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
International Patents for Navitoclax
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Navitoclax | Australia | 2006297853 | 2025-05-12 | ➤ Sign Up |
| Navitoclax | Australia | 2010233055 | 2025-05-12 | ➤ Sign Up |
| Navitoclax | Australia | 2010326090 | 2025-05-12 | ➤ Sign Up |
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
